Drug Delivery

12/26/2023 | Jamie Irvine | 3 min read

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Discovery & Development Drug Delivery

12/21/2023 | Jamie Irvine | 3 min read

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

Manufacture Bioprocessing - Upstream & Downstream

12/18/2023 | Brecht Vanbillemont, Andrea Arsiccio | 3 min read

Academia suggests we need to upgrade lyophilization, but scientists are being slow to respond

Discovery & Development Drug Delivery

12/07/2023 | Jamie Irvine | 2 min read

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

Manufacture Advanced Medicine

11/08/2023 | Jamie Irvine | 3 min read

How a three-way collaboration aims to use digital twins to refine the efficiency of adeno-associated virus manufacture

Discovery & Development Drug Delivery

10/27/2023 | Jamie Irvine | 4 min read

Researchers genetically modify chickens to build bird-flu resistance – read more here.

Discovery & Development Formulation

10/18/2023 | Helen Kuhlman | 4 min read

Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?

Manufacture Advanced Medicine

10/10/2023 | Jamie Irvine

Editas and Azzur Group scale up their efforts against sickle cell disease with experimental gene editing medicine EDIT-301

Discovery & Development Drug Delivery

10/09/2023 | Nicholas (Nik) Barbet | 4 min read

Here’s why virus-like particles could open a new chapter in combating disease.

Discovery & Development Drug Delivery

10/06/2023 | Jamie Irvine | 2 min read

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor